P2RY2 and dry eye syndrome: Diquafosol tetrasodium, a uridine-5′-triphosphate (UTP) analogue and P2Y2 agonist that stimulates ophthalmic secretions has been approved as a therapeutic option for dry eye syndrome and accommodative spasm in some Asian countries [31,34].